TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Medicines Discovery Catapult - Electronic Laboratory Notebook (ELN) and Laboratory Information Management System (LIMS)

Software package and information systems
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: MEDICINES DISCOVERY CATAPULT LIMITED: "Medicines Discovery Catapult - Electronic Laboratory Notebook (ELN) and Laboratory Information Management System (LIMS)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityMEDICINES DISCOVERY CATAPULT LIMITEDScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: MEDICINES DISCOVERY CATAPULT LIMITED
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for MEDICINES DISCOVERY CATAPULT LIMITED. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1Bids / Report
100% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 2 active published awards; 2 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published5 Mar 2024, 09:04 GMT
Last source update5 Mar 2024, 09:04 GMT
Recurring procurementNot published
ClassificationSoftware package and information systems
Delivery area
UK
OCIDocds-h6vhtk-03d6a9
What is being bought
Research data is the primary deliverable of MDC and it is essential to have an evident and secure way of its documentation. The data will be used to advance internal capability-build and external fee-for-service research projects from a diverse set of scientific technologies, including Mass Spectrometry, Imaging, In-vivo Imaging, Complex Cells, Biomarker and Target Engagement & Validation studies. Consistent with MDC's vision of collaborative working, the platform must enable seamless data sharing for internal and external projects with scientists and institutions. The software's main task is to document research data and to provide evidence of Good Laboratory Practice as well as improving lab productivity and efficiency, by keeping track of data associated with samples, experiments, laboratory workflows, and instruments. MDC does not currently have a commercial ELN as the previous ELN contract ended in July 2021. The current means of tracking samples and laboratory consumables is a combination of paper-based documentation and Microsoft spreadsheets. This is no longer fit for purpose as the business expands and diversifies to include work with clinical samples. As such, MDC now requires a robust LIMS with full traceability to ensure that quality is maintained and to readily demonstrate the integrity of work involving clinical samples.
What changed
From the official release history
  1. Status changed to complete
    5 Mar 2024, 09:04 GMT
  2. Official notice release published
    5 Mar 2024, 09:04 GMT
  3. Submission deadline changed to published date
    5 Mar 2024, 09:04 GMT
  4. Buyer information updated
    5 Mar 2024, 09:04 GMT
  5. Status changed to active
    15 Jun 2023, 15:12 BST
  6. Official notice release published
    15 Jun 2023, 15:12 BST
  7. Submission deadline changed to 17 Jul 2023, 12:00 BST
    15 Jun 2023, 15:12 BST
  8. Buyer information updated
    15 Jun 2023, 15:12 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Research data is the primary deliverable of MDC and it is essential to have an evident and secure way of its documentation. The data will be used to advance internal capability-build and external fee-for-service research projects from a diverse set of scientific technologies, including Mass Spectrometry, Imaging, In-vivo Imaging, Complex Cells, Biomarker and Target Engagement & Validation studies. Consistent with MDC's vision of collaborative working, the platform must enable seamless data sharing for internal and external projects with scientists and institutions. The software's main task is to document research data and to provide evidence of Good Laboratory Practice as well as improving lab productivity and efficiency, by keeping track of data associated with samples, experiments, laboratory workflows, and instruments. MDC does not currently have a commercial ELN as the previous ELN contract ended in July 2021. The current means of tracking samples and laboratory consumables is a combination of paper-based documentation and Microsoft spreadsheets. This is no longer fit for purpose as the business expands and diversifies to include work with clinical samples. As such, MDC now requires a robust LIMS with full traceability to ensure that quality is maintained and to readily demonstrate the integrity of work involving clinical samples.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    5 Mar 2024, 09:04 GMT
  2. Award unsuccessful
    Not published · Not published
Commercial outcome and competition
Awards
Awarded supplier not published
Not published · Not published · unsuccessful
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

MEDICINES DISCOVERY CATAPULT LIMITED

Contracting authority GB-FTS-106783
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published